Association of a vitamin D receptor polymorphism with sporadic breast cancer development

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 723-726

  Curran, Joanne E ^a   Vaughan, Tanya ^a   Lea, Rod A ^a   Weinstein, Stephen R ^b   Morrison, Nigel A ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BONE METASTASIS; BREAST CARCINOGENESIS; BREAST CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; REFERENCE VALUES;

EID: 0032735893     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO;2-3     Document Type: Article

References (22)

1. CARLING, T., KINDMARK, A., HELLMAN, P., HOLMBERG, L., AKERSTROM, G. and RASTAD, J., Vitamin D receptor alleles b, a and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN1. Biochem. Biophys. Res. Commun., 231, 329-332 (1997).
2. CARLING, T., KINDMARK, A., HELLMAN, P., LUNDGREN, E., LJUNGHALL, S., RASTAD, J., AKERSTROM, G. and MELHUS, H., Vitamin D receptor genotypes in primary hyperparathyroidism. Nature (Med.), 12, 1309-1311 (1995).
3. COATES, M. and ARMSTRONG, B., Cancer in New South Wales: incidence and mortality 1994. New South Wales Cancer Council, Sydney (1997).
4. COLSTON, K., Vitamin D and breast cancer: therapeutic potential of new vitamin D analogs. In D. Feldman, F.H. Glorieux and J.W. Pike (eds.), Vitamin D. pp. 1107-1123, Academic Press, San Diego (1997).
5. CROFTS, L.A., HANCOCK, M.S., MORRISON, N.A. and EISMAN, J.A., Multiple promoters and novel N-terminal variant human vitamin D receptor transcripts. Proc. nat. Acad. Sci. Wash., 95, 10529-10534 (1998).
6. DEVILEE, P. and CORNELISSE, C.J., Somatic genetic changes in human breast cancer. Biochim. biophys Acta. 1198, 113-130 (1994).
7. EISMAN, J.A., MARTIN, T.J., MACINTYRE, I. and MOSELEY, J.M., 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet, 2, 1335-1336 (1979).
8. GULLIFORD, T., ENGLISH, J., COLSTON, K.W., MENDAY, P., MOLLER, S. and COOMBES, R.C., A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Brit. J. Cancer, 78, 6-13 (1996).
9. HARRIS, S.S., ECCLESHALL, T.R., GROSS, C., DAWSON-HUGHES, B. and FELDMAN, D., The vitamin D receptor start codon polymorphism (Fok1) and bone mineral density in premenopausal American black and white women. J. Bone Miner. Res., 12, 1043-1048 (1997).
10. INGLES, S.A., HAILE, R., HENDERSON, B., KOLONEL, L. and COETZEE, G., Association of vitamin D receptor genetic polymorphism with breast cancer risk in African-American and Hispanic Women. In A.W. Norman, R. Bouillon and M. Thomasset (eds.), Vitamin D: chemistry, biology and clinical applications of the steroid hormone, pp. 811-812, University of California, Los Angeles (1997a).
11. INGLES, S.A., ROSS, R.K., YU, M.C., IRVINE, R.A., LA PERA, G., HAILE, R.W., and COETZEE, G.A., Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. nat. Cancer Inst., 89, 166-170 (1997b).
12. JAMES, S.Y., MACKAY, A.G. and COLSTON, K.W. Effecls of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem., 58, 395-401 (1996).
13. JENKINS, R., KELSALL, J., BUNDRED, N.. HOWELL, A. and MAWER, B., Vitamin D receptor polymorphisms in breast cancer patients. In A.W. Norman, R. Bouillon and M. Thomasset (eds.), Vitamin D: chemistry, biology and clinical applications of the steroid hormone, pp. 811-812, University of California, Los Angeles (1997).
14. JONES, K.A., BROWN, M.A. and SOLOMON, E., Molecular genetics of sporadic and familial breast cancer. Cancer Surv., 25, 315-334 (1995).
15. KELSEY, J.L., Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15, 256-263 (1993).
16. LEA, R.A., SELVEY, S., ASHTON, K.J., CURRAN, J.E. GAFFNEY, P.T., GREEN, A.C. and GRIFFITHS, L.R., The null allele of GSTM1 does not affect susceptibility to solar keratoses in the Australian white population. J. Amer. Acad. Dermatol., 38, 631-633 (1998).
17. MAWER, E.B., WALLS, J., HOWELL, A., DAVIES, M., RATCLIFFE, W.A. and BUNDRED, N.J., Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J. Clin. Endocrinol. Metab., 82, 118-122 (1997).
18. MORRISON, N.A., Qi, J.-C., TOKITA, A., KELLY, P., CROFTS, L., NGUYEN, T., SAMBROOK, P. and EISMAN, J.A., Prediction of bone density from vitamin D receptor alleles. Nature (Lond.), 367, 284-287 (1994).
19. PIKE, J.W., The vitamin D receptor and its gene. In D. Feldman, F.H. Glorieux and J.W. Pike (eds.), Vitamin D, pp. 1107-1123, Academic Press, San Diego (1997).
20. RUGGIERO, M., PACINI, S., ATERINI, S., FALLAI, C., RUGGIERO, C. and PACINI, P., Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol. Res., 10, 43-46 (1998).
21. SAINZ, J., VAN TORNOUT, J.M., LORO, M.L., SAYRE, J., ROE, T.F. and GILSANZ, V., Vitamin D receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N. Engl. J. Med., 337, 77-82 (1997).
22. TAYLOR, J.A., HIRVONEN, A., WATSON, M., PITTMAN, G., MOHLER, J.L. and BELL, D.A., Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res., 56, 4108-4110 (1996).